“This Isn’t The Past Novartis,” Jimenez Tells J.P. Morgan Conference
This article was originally published in The Pink Sheet Daily
The CEO of Novartis talked about some of the ways the big pharma has changed its approach to business and research by making faster decisions.
You may also be interested in...
The virtual J.P. Morgan Healthcare meeting was missing the usual energy but still had substance.
US vaccination campaign will pick up speed now that access is broadening, leaders from Operation Warp Speed, Pfizer, Moderna, McKesson and CVS Health say at a J.P. Morgan panel discussion.
Vir believes its single antibody will be effective against rising mutant forms of COVID-19. Phase III data from two ongoing trials are expected in the first quarter.